-
1
-
-
53549114206
-
NK cells and cancer immunosurveillance
-
Waldhauer, I and Steinle, A (2008). NK cells and cancer immunosurveillance. Oncogene 27: 5932-5943.
-
(2008)
Oncogene
, vol.27
, pp. 5932-5943
-
-
Waldhauer, I.1
Steinle, A.2
-
2
-
-
53549124398
-
NKG2D ligands in tumor immunity
-
Nausch, N and Cerwenka, A (2008). NKG2D ligands in tumor immunity. Oncogene 27: 5944-5958.
-
(2008)
Oncogene
, vol.27
, pp. 5944-5958
-
-
Nausch, N.1
Cerwenka, A.2
-
3
-
-
33745567831
-
Self-tolerance of natural killer cells
-
Raulet, DH and Vance, RE (2006). Self-tolerance of natural killer cells. Nat Rev Immunol 6: 520-531.
-
(2006)
Nat Rev Immunol
, vol.6
, pp. 520-531
-
-
Raulet, D.H.1
Vance, R.E.2
-
4
-
-
37549028403
-
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: A lesson for the use of recombinant immunoreceptors as an immunological tool
-
Hershkovitz, O, Jarahian, M, Zilka, A, Bar-Ilan, A, Landau, G, Jivov, S et al. (2008). Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool. Glycobiology 18: 28-41.
-
(2008)
Glycobiology
, vol.18
, pp. 28-41
-
-
Hershkovitz, O.1
Jarahian, M.2
Zilka, A.3
Bar-Ilan, A.4
Landau, G.5
Jivov, S.6
-
5
-
-
82755186747
-
Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44
-
Rosental, B, Brusilovsky, M, Hadad, U, Oz, D, Appel, MY, Afergan, F et al. (2011). Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J Immunol 187: 5693-5702.
-
(2011)
J Immunol
, vol.187
, pp. 5693-5702
-
-
Rosental, B.1
Brusilovsky, M.2
Hadad, U.3
Oz, D.4
Appel, M.Y.5
Afergan, F.6
-
6
-
-
34250803843
-
Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44
-
Hershkovitz, O, Jivov, S, Bloushtain, N, Zilka, A, Landau, G, Bar-Ilan, A et al. (2007). Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry 46: 7426-7436.
-
(2007)
Biochemistry
, vol.46
, pp. 7426-7436
-
-
Hershkovitz, O.1
Jivov, S.2
Bloushtain, N.3
Zilka, A.4
Landau, G.5
Bar-Ilan, A.6
-
7
-
-
37049037976
-
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells
-
Pogge von Strandmann, E, Simhadri, VR, von Tresckow, B, Sasse, S, Reiners, KS, Hansen, HP et al. (2007). Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27: 965-974.
-
(2007)
Immunity
, vol.27
, pp. 965-974
-
-
Pogge Von Strandmann, E.1
Simhadri, V.R.2
Von Tresckow, B.3
Sasse, S.4
Reiners, K.S.5
Hansen, H.P.6
-
8
-
-
67650507057
-
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
-
Brandt, CS, Baratin, M, Yi, EC, Kennedy, J, Gao, Z, Fox, B et al. (2009). The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 206: 1495-1503.
-
(2009)
J Exp Med
, vol.206
, pp. 1495-1503
-
-
Brandt, C.S.1
Baratin, M.2
Yi, E.C.3
Kennedy, J.4
Gao, Z.5
Fox, B.6
-
9
-
-
24944500112
-
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
-
Oppenheim, DE, Roberts, SJ, Clarke, SL, Filler, R, Lewis, JM, Tigelaar, RE et al. (2005). Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 6: 928-937.
-
(2005)
Nat Immunol
, vol.6
, pp. 928-937
-
-
Oppenheim, D.E.1
Roberts, S.J.2
Clarke, S.L.3
Filler, R.4
Lewis, J.M.5
Tigelaar, R.E.6
-
10
-
-
23944519927
-
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
-
Coudert, JD, Zimmer, J, Tomasello, E, Cebecauer, M, Colonna, M, Vivier, E et al. (2005). Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 106: 1711-1717.
-
(2005)
Blood
, vol.106
, pp. 1711-1717
-
-
Coudert, J.D.1
Zimmer, J.2
Tomasello, E.3
Cebecauer, M.4
Colonna, M.5
Vivier, E.6
-
11
-
-
0037126310
-
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
-
Groh, V, Wu, J, Yee, C and Spies, T (2002). Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738.
-
(2002)
Nature
, vol.419
, pp. 734-738
-
-
Groh, V.1
Wu, J.2
Yee, C.3
Spies, T.4
-
12
-
-
34249295619
-
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands
-
Kaiser, BK, Yim, D, Chow, IT, Gonzalez, S, Dai, Z, Mann, HH et al. (2007). Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447: 482-486.
-
(2007)
Nature
, vol.447
, pp. 482-486
-
-
Kaiser, B.K.1
Yim, D.2
Chow, I.T.3
Gonzalez, S.4
Dai, Z.5
Mann, H.H.6
-
13
-
-
0041737499
-
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
-
Salih, HR, Antropius, H, Gieseke, F, Lutz, SZ, Kanz, L, Rammensee, HG et al. (2003). Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102: 1389-1396.
-
(2003)
Blood
, vol.102
, pp. 1389-1396
-
-
Salih, H.R.1
Antropius, H.2
Gieseke, F.3
Lutz, S.Z.4
Kanz, L.5
Rammensee, H.G.6
-
14
-
-
42649119742
-
Soluble NKG2D ligands: Prevalence, release, and functional impact
-
Salih, HR, Holdenrieder, S and Steinle, A (2008). Soluble NKG2D ligands: prevalence, release, and functional impact. Front Biosci 13: 3448-3456.
-
(2008)
Front Biosci
, vol.13
, pp. 3448-3456
-
-
Salih, H.R.1
Holdenrieder, S.2
Steinle, A.3
-
15
-
-
69349104067
-
Differential clinical signifcance of individual NKG2D ligands in melanoma: Soluble ULBP2 as an indicator of poor prognosis superior to S100B
-
Paschen, A, Sucker, A, Hill, B, Moll, I, Zapatka, M, Nguyen, XD et al. (2009). Differential clinical signifcance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B. Clin Cancer Res 15: 5208-5215.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5208-5215
-
-
Paschen, A.1
Sucker, A.2
Hill, B.3
Moll, I.4
Zapatka, M.5
Nguyen, X.D.6
-
16
-
-
61349167118
-
Clinical signifcance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: High expression of ULBP2 is an indicator of poor prognosis
-
Li, K, Mandai, M, Hamanishi, J, Matsumura, N, Suzuki, A, Yagi, H et al. (2009). Clinical signifcance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. Cancer Immunol Immunother 58: 641-652.
-
(2009)
Cancer Immunol Immunother
, vol.58
, pp. 641-652
-
-
Li, K.1
Mandai, M.2
Hamanishi, J.3
Matsumura, N.4
Suzuki, A.5
Yagi, H.6
-
17
-
-
84864131272
-
Comprehensive analysis of NKG2D ligand expression and release in leukemia: Implications for NKG2D-mediated NK cell responses
-
Hilpert, J, Grosse-Hovest, L, Grünebach, F, Buechele, C, Nuebling, T, Raum, T et al. (2012). Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses. J Immunol 189: 1360-1371.
-
(2012)
J Immunol
, vol.189
, pp. 1360-1371
-
-
Hilpert, J.1
Grosse-Hovest, L.2
Grünebach, F.3
Buechele, C.4
Nuebling, T.5
Raum, T.6
-
18
-
-
0020428728
-
Low natural killer cell activity in patients with malignant lymphoma
-
Tursz, T, Dokhelar, MC, Lipinski, M and Amiel, JL (1982). Low natural killer cell activity in patients with malignant lymphoma. Cancer 50: 2333-2335.
-
(1982)
Cancer
, vol.50
, pp. 2333-2335
-
-
Tursz, T.1
Dokhelar, M.C.2
Lipinski, M.3
Amiel, J.L.4
-
19
-
-
0032924630
-
The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease
-
Konjevic, G, Jurisic, V, Banicevic, B and Spuzic, I (1999). The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease. Br J Haematol 104: 144-151.
-
(1999)
Br J Haematol
, vol.104
, pp. 144-151
-
-
Konjevic, G.1
Jurisic, V.2
Banicevic, B.3
Spuzic, I.4
-
20
-
-
42449102990
-
Up on the tightrope: Natural killer cell activation and inhibition
-
Lanier, LL (2008). Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495-502.
-
(2008)
Nat Immunol
, vol.9
, pp. 495-502
-
-
Lanier, L.L.1
-
21
-
-
77955983259
-
Anti-CD30 Antibodies for Hodgkin lymphoma
-
Foyil, KV and Bartlett, NL (2010). Anti-CD30 Antibodies for Hodgkin lymphoma. Curr Hematol Malig Rep 5: 140-147.
-
(2010)
Curr Hematol Malig Rep
, vol.5
, pp. 140-147
-
-
Foyil, K.V.1
Bartlett, N.L.2
-
22
-
-
79954438055
-
Hodgkin's lymphoma: Current treatment strategies and novel approaches
-
Eichenauer, DA, Fuchs, M, Borchmann, P and Engert, A; German Hodgkin Study Group (2008). Hodgkin's lymphoma: current treatment strategies and novel approaches. Expert Rev Hematol 1: 63-73.
-
(2008)
Expert Rev Hematol
, vol.1
, pp. 63-73
-
-
Eichenauer, D.A.1
Fuchs, M.2
Borchmann, P.3
Engert, A.4
-
23
-
-
79955877897
-
Molecular pathogenesis of Hodgkin's lymphoma: Increasing evidence of the importance of the microenvironment
-
Steidl, C, Connors, JM and Gascoyne, RD (2011). Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment. J Clin Oncol 29: 1812-1826.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1812-1826
-
-
Steidl, C.1
Connors, J.M.2
Gascoyne, R.D.3
-
24
-
-
0034060217
-
Frequent lack of translation of antigen presentation-associated molecules MHC class I, CD1a and Beta(2)-microglobulin in Reed-Stern berg cells
-
Van den Berg, A, Visser, L, Eberwine, J, Dadvand, L and Poppema, S (2000). Frequent lack of translation of antigen presentation-associated molecules MHC class I, CD1a and Beta(2)-microglobulin in Reed-Sternberg cells. Int J Cancer 86: 548-552.
-
(2000)
Int J Cancer
, vol.86
, pp. 548-552
-
-
Van Den Berg, A.1
Visser, L.2
Eberwine, J.3
Dadvand, L.4
Poppema, S.5
-
25
-
-
47249093196
-
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D
-
Krockenberger, M, Dombrowski, Y, Weidler, C, Ossadnik, M, Hönig, A, Häusler, S et al. (2008). Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D. J Immunol 180: 7338-7348.
-
(2008)
J Immunol
, vol.180
, pp. 7338-7348
-
-
Krockenberger, M.1
Dombrowski, Y.2
Weidler, C.3
Ossadnik, M.4
Hönig, A.5
Häusler, S.6
-
26
-
-
80054703162
-
Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression
-
Mittelbronn, M, Platten, M, Zeiner, P, Dombrowski, Y, Frank, B, Zachskorn, C et al. (2011). Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression. Acta Neuropathol 122: 353-365.
-
(2011)
Acta Neuropathol
, vol.122
, pp. 353-365
-
-
Mittelbronn, M.1
Platten, M.2
Zeiner, P.3
Dombrowski, Y.4
Frank, B.5
Zachskorn, C.6
-
27
-
-
79960637590
-
Protein targeting and degradation are coupled for elimination of mislocalized proteins
-
Hessa, T, Sharma, A, Mariappan, M, Eshleman, HD, Gutierrez, E and Hegde, RS (2011). Protein targeting and degradation are coupled for elimination of mislocalized proteins. Nature 475: 394-397.
-
(2011)
Nature
, vol.475
, pp. 394-397
-
-
Hessa, T.1
Sharma, A.2
Mariappan, M.3
Eshleman, H.D.4
Gutierrez, E.5
Hegde, R.S.6
-
28
-
-
79959906869
-
Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase
-
Jiang, W, Wang, S, Xiao, M, Lin, Y, Zhou, L, Lei, Q et al. (2011). Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol Cell 43: 33-44.
-
(2011)
Mol Cell
, vol.43
, pp. 33-44
-
-
Jiang, W.1
Wang, S.2
Xiao, M.3
Lin, Y.4
Zhou, L.5
Lei, Q.6
-
29
-
-
34147156192
-
HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53
-
Sasaki, T, Gan, EC, Wakeham, A, Kornbluth, S, Mak, TW and Okada, H (2007). HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev 21: 848-861.
-
(2007)
Genes Dev
, vol.21
, pp. 848-861
-
-
Sasaki, T.1
Gan, E.C.2
Wakeham, A.3
Kornbluth, S.4
Mak, T.W.5
Okada, H.6
-
30
-
-
78650689674
-
Hodgkin's lymphoma: The role of cell surface receptors in regulation of tumor cell fate
-
Yurchenko, M and Sidorenko, SP (2010). Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate. Exp Oncol 32: 214-223.
-
(2010)
Exp Oncol
, vol.32
, pp. 214-223
-
-
Yurchenko, M.1
Sidorenko, S.P.2
-
31
-
-
0032855541
-
A bispecifc diabody that mediates natural killer cell cytotoxicity against xenotransplantated human Hodgkin's tumors
-
Arndt, MA, Krauss, J, Kipriyanov, SM, Pfreundschuh, M and Little, M (1999). A bispecifc diabody that mediates natural killer cell cytotoxicity against xenotransplantated human Hodgkin's tumors. Blood 94: 2562-2568.
-
(1999)
Blood
, vol.94
, pp. 2562-2568
-
-
Arndt, M.A.1
Krauss, J.2
Kipriyanov, S.M.3
Pfreundschuh, M.4
Little, M.5
-
32
-
-
0036644046
-
Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells
-
Pisegna, S, Zingoni, A, Pirozzi, G, Cinque, B, Cifone, MG, Morrone, S et al. (2002). Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells. J Immunol 169: 68-74.
-
(2002)
J Immunol
, vol.169
, pp. 68-74
-
-
Pisegna, S.1
Zingoni, A.2
Pirozzi, G.3
Cinque, B.4
Cifone, M.G.5
Morrone, S.6
-
33
-
-
84856836302
-
High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas
-
Zocchi, MR, Catellani, S, Canevali, P, Tavella, S, Garuti, A, Villaggio, B et al. (2012). High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas. Blood 119: 1479-1489.
-
(2012)
Blood
, vol.119
, pp. 1479-1489
-
-
Zocchi, M.R.1
Catellani, S.2
Canevali, P.3
Tavella, S.4
Garuti, A.5
Villaggio, B.6
-
34
-
-
41549163195
-
NKG2D-defcient mice are defective in tumor surveillance in models of spontaneous malignancy
-
Guerra, N, Tan, YX, Joncker, NT, Choy, A, Gallardo, F, Xiong, N et al. (2008). NKG2D-defcient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28: 571-580.
-
(2008)
Immunity
, vol.28
, pp. 571-580
-
-
Guerra, N.1
Tan, Y.X.2
Joncker, N.T.3
Choy, A.4
Gallardo, F.5
Xiong, N.6
-
35
-
-
77954613267
-
The prognostic signifcance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia
-
Nückel, H, Switala, M, Sellmann, L, Horn, PA, Dürig, J, Dührsen, U et al. (2010). The prognostic signifcance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia 24: 1152-1159.
-
(2010)
Leukemia
, vol.24
, pp. 1152-1159
-
-
Nückel, H.1
Switala, M.2
Sellmann, L.3
Horn, P.A.4
Dürig, J.5
Dührsen, U.6
-
36
-
-
33845987986
-
Defcient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
-
Fauriat, C, Just-Landi, S, Mallet, F, Arnoulet, C, Sainty, D, Olive, D et al. (2007). Defcient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood 109: 323-330.
-
(2007)
Blood
, vol.109
, pp. 323-330
-
-
Fauriat, C.1
Just-Landi, S.2
Mallet, F.3
Arnoulet, C.4
Sainty, D.5
Olive, D.6
-
37
-
-
80155132470
-
Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition
-
Mamessier, E, Sylvain, A, Bertucci, F, Castellano, R, Finetti, P, Houvenaeghel, G et al. (2011). Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition. Cancer Res 71: 6621-6632.
-
(2011)
Cancer Res
, vol.71
, pp. 6621-6632
-
-
Mamessier, E.1
Sylvain, A.2
Bertucci, F.3
Castellano, R.4
Finetti, P.5
Houvenaeghel, G.6
-
38
-
-
79958118266
-
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
-
Delahaye, NF, Rusakiewicz, S, Martins, I, Ménard, C, Roux, S, Lyonnet, L et al. (2011). Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat Med 17: 700-707.
-
(2011)
Nat Med
, vol.17
, pp. 700-707
-
-
Delahaye, N.F.1
Rusakiewicz, S.2
Martins, I.3
Ménard, C.4
Roux, S.5
Lyonnet, L.6
-
39
-
-
80052346280
-
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
-
Mamessier, E, Sylvain, A, Thibult, ML, Houvenaeghel, G, Jacquemier, J, Castellano, R et al. (2011). Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 121: 3609-3622.
-
(2011)
J Clin Invest
, vol.121
, pp. 3609-3622
-
-
Mamessier, E.1
Sylvain, A.2
Thibult, M.L.3
Houvenaeghel, G.4
Jacquemier, J.5
Castellano, R.6
-
40
-
-
0030974954
-
Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecifc antibody
-
Hartmann, F, Renner, C, Jung, W, Deisting, C, Juwana, M, Eichentopf, B et al. (1997). Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecifc antibody. Blood 89: 2042-2047.
-
(1997)
Blood
, vol.89
, pp. 2042-2047
-
-
Hartmann, F.1
Renner, C.2
Jung, W.3
Deisting, C.4
Juwana, M.5
Eichentopf, B.6
-
41
-
-
33646559241
-
Deciphering CD30 ligand biology and its role in humoral immunity
-
Kennedy, MK, Willis, CR and Armitage, RJ (2006). Deciphering CD30 ligand biology and its role in humoral immunity. Immunology 118: 143-152.
-
(2006)
Immunology
, vol.118
, pp. 143-152
-
-
Kennedy, M.K.1
Willis, C.R.2
Armitage, R.J.3
-
42
-
-
0037716818
-
Natural killer cell receptor signaling
-
Lanier, LL (2003). Natural killer cell receptor signaling. Curr Opin Immunol 15: 308-314.
-
(2003)
Curr Opin Immunol
, vol.15
, pp. 308-314
-
-
Lanier, L.L.1
-
43
-
-
0034076307
-
Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets
-
Clynes, RA, Towers, TL, Presta, LG and Ravetch, JV (2000). Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med 6: 443-446.
-
(2000)
Nat Med
, vol.6
, pp. 443-446
-
-
Clynes, R.A.1
Towers, T.L.2
Presta, L.G.3
Ravetch, J.V.4
-
44
-
-
0031905710
-
Fc receptors are required in passive and active immunity to melanoma
-
Clynes, R, Takechi, Y, Moroi, Y, Houghton, A and Ravetch, JV (1998). Fc receptors are required in passive and active immunity to melanoma. Proc Natl Acad Sci USA 95: 652-656.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 652-656
-
-
Clynes, R.1
Takechi, Y.2
Moroi, Y.3
Houghton, A.4
Ravetch, J.V.5
-
45
-
-
33845944538
-
Tumor-primed human natural killer cells lyse NK-resistant tumor targets: Evidence of a two-stage process in resting NK cell activation
-
North, J, Bakhsh, I, Marden, C, Pittman, H, Addison, E, Navarrete, C et al. (2007). Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation. J Immunol 178: 85-94.
-
(2007)
J Immunol
, vol.178
, pp. 85-94
-
-
North, J.1
Bakhsh, I.2
Marden, C.3
Pittman, H.4
Addison, E.5
Navarrete, C.6
-
46
-
-
75149162957
-
Requirements for control of B-cell lymphoma by NK cells
-
Brenner, CD, King, S, Przewoznik, M, Wolters, I, Adam, C, Bornkamm, GW et al. (2010). Requirements for control of B-cell lymphoma by NK cells. Eur J Immunol 40: 494-504.
-
(2010)
Eur J Immunol
, vol.40
, pp. 494-504
-
-
Brenner, C.D.1
King, S.2
Przewoznik, M.3
Wolters, I.4
Adam, C.5
Bornkamm, G.W.6
-
47
-
-
84863676500
-
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma
-
Younes, A, Gopal, AK, Smith, SE, Ansell, SM, Rosenblatt, JD, Savage, KJ et al. (2012). Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. J Clin Oncol 30: 2183-2189.
-
(2012)
J Clin Oncol
, vol.30
, pp. 2183-2189
-
-
Younes, A.1
Gopal, A.K.2
Smith, S.E.3
Ansell, S.M.4
Rosenblatt, J.D.5
Savage, K.J.6
-
48
-
-
84867580896
-
T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecifc tetravalent antibody CD19 × CD3 or CD19 × CD16
-
Pörtner, LM, Schönberg, K, Hejazi, M, Brünnert, D, Neumann, F, Galonska, L et al. (2012). T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecifc tetravalent antibody CD19 × CD3 or CD19 × CD16. Cancer Immunol Immunother 61: 1869-1875.
-
(2012)
Cancer Immunol Immunother
, vol.61
, pp. 1869-1875
-
-
Pörtner, L.M.1
Schönberg, K.2
Hejazi, M.3
Brünnert, D.4
Neumann, F.5
Galonska, L.6
-
49
-
-
42449123606
-
Natural killer cell-directed therapies: Moving from unexpected results to successful strategies
-
Terme, M, Ullrich, E, Delahaye, NF, Chaput, N and Zitvogel, L (2008). Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol 9: 486-494.
-
(2008)
Nat Immunol
, vol.9
, pp. 486-494
-
-
Terme, M.1
Ullrich, E.2
Delahaye, N.F.3
Chaput, N.4
Zitvogel, L.5
-
50
-
-
33344477900
-
A novel bispecifc protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo
-
von Strandmann, EP, Hansen, HP, Reiners, KS, Schnell, R, Borchmann, P, Merkert, S et al. (2006). A novel bispecifc protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo. Blood 107: 1955-1962.
-
(2006)
Blood
, vol.107
, pp. 1955-1962
-
-
Von Strandmann, E.P.1
Hansen, H.P.2
Reiners, K.S.3
Schnell, R.4
Borchmann, P.5
Merkert, S.6
|